Aprea Therapeutics, Inc. Foreign Currency Transaction Gain, before Tax
Aprea Therapeutics, Inc. (APRE) reported Foreign Currency Transaction Gain, before Tax of $2.59 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionGainBeforeTax · last filed 2019-11-14
- 2019-09-30: Foreign Currency Transaction Gain, before Tax 9 month $2.59M.
- 2018-09-30: Foreign Currency Transaction Gain, before Tax 9 month $741.62K.
| Period end | Foreign Currency Transaction Gain, before Tax 9 month |
|---|---|
| 2019-09-30 | $2.59M 10-Q · filed 2019-11-14 |
| 2018-09-30 | $741.62K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |